The sale of the Nerviano plant of Pfizer Global Manufacturing, a division of Pfizer, to the Icelandic company Actavis Group, one of the leading companies in the pharmaceutical sector worldwide, is currently BEING DEFINED. All 340 current employees will continue to work at the plant under the new company. According to what was announced by Pfizer, the conclusion of the transaction is expected by the end of January. Actavis Group, concentrated in the development, production and sale of generic drugs will continue to ensure productions for Pfizer. The Day of 20/01/2008 ed. LEGNANO p. YOU
